• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Datatrak Looks for Strategic Alternatives

Datatrak Looks for Strategic Alternatives

July 30, 2008
CenterWatch Staff

Cleveland-based Datatrak International, a struggling electronic data capture (EDC) vendor, has retained Healthcare Growth Partners (HGP) as a strategic and financial advisor to assist its Board of Directors in evaluating a variety of potential opportunities directed at maximizing shareholder value.

These potential opportunities may include, but are not limited to, a sale, merger or other business combination of the company; strategic partnerships or alliances; or the raising of additional capital, should the company determine it is in the best interest of its shareholders to continue as a stand alone entity. HGP focuses exclusively on healthcare technology and related service-based organizations, providing strategic, operational and transaction advisory services to small and mid-sized healthcare companies.

“Over the past year we have focused on stabilizing our business through the optimization of our expense levels and staffing, while simultaneously continuing to advance our technology platform as we position our company to capitalize on the advantages of our unique single user interface and database architecture,” said Jeffrey Green, chief executive officer of Datatrak International. “We believe the maturation of this industry towards a single platform approach will eventually be realized because this creates optimum efficiencies for clinical trial sponsors and contract research organizations.”

Upcoming Events

  • 15Apr

    Five Telltale Signs You’re Ready for an Electronic TMF System

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

  • 06May

    The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Clinical-Trial-Brainstorming

    FDA, Industry Tackle Problem of Including Older Adults in Trials

  • ClinicalTrialNetwork-360x240.png

    National Community-Based Research Network Would Improve Reach of Trials

  • Bottleneck-360x240.png

    Sites Face Trials Bottleneck After Pandemic, But Also Opportunities

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Genetic Research and IBC Oversight Requirements

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing